BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Tumor necrosis factor receptor 2 (TNFR2)

September 1, 2016 7:00 AM UTC

Cell culture, patient sample and mouse studies suggest agonizing TNFR2 could help prevent or treat acute GvHD. In Tregs from mice or healthy volunteers, a mouse or human TNFR2 agonist tool compound, r...